{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Detroit&page=33&state=Michigan", "query": { "state": "Michigan", "city": "Detroit", "page": 33 }, "page_size": 10 }, "pagination": { "page": 33, "page_size": 10, "total_count": 7238, "total_pages": 724, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Detroit&page=34&state=Michigan&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Detroit&page=32&state=Michigan&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-02T01:25:45.047Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01667744", "title": "Citalopram for Sx/Util in Acute Coronary Syndrome Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Acute Coronary Syndrome" ], "interventions": [ { "name": "Citalopram", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Henry Ford Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2016-01-01", "completion_date": "2021-02-16", "has_results": false, "last_update_posted_date": "2022-12-09", "last_synced_at": "2026-11-02T01:25:45.047Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01667744" }, { "nct_id": "NCT06022939", "title": "Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "AL Amyloidosis" ], "interventions": [ { "name": "Autologous Hematopoietic Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Biopsy", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Bortezomib", "type": "DRUG" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Daratumumab and Hyaluronidase-fihj", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Echocardiography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Melphalan", "type": "DRUG" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Stem Cell Isolation", "type": "PROCEDURE" }, { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 338, "start_date": "2024-07-01", "completion_date": "2030-10-29", "has_results": false, "last_update_posted_date": "2026-05-06", "last_synced_at": "2026-11-02T01:25:45.047Z", "location_count": 117, "location_summary": "Goodyear, Arizona • Tucson, Arizona • Duarte, California + 93 more", "locations": [ { "city": "Goodyear", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06022939" }, { "nct_id": "NCT00002912", "title": "Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Leukemia" ], "interventions": [ { "name": "etoposide", "type": "DRUG" }, { "name": "mitoxantrone hydrochloride", "type": "DRUG" }, { "name": "valspodar", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 3, "start_date": "1997-01", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-02-01", "last_synced_at": "2026-11-02T01:25:45.047Z", "location_count": 50, "location_summary": "Little Rock, Arkansas • La Jolla, California • Los Angeles, California + 39 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002912" }, { "nct_id": "NCT01252628", "title": "Phase 1 and 2 Study of PX-866 and Cetuximab", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Incurable Metastatic Colorectal Carcinoma", "Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck" ], "interventions": [ { "name": "PX-866 (SCCHN)", "type": "DRUG" }, { "name": "Cetuximab (SCCHN)", "type": "DRUG" }, { "name": "PX-866 (CRC)", "type": "DRUG" }, { "name": "Cetuximab (CRC)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cascadian Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 178, "start_date": "2010-12", "completion_date": "2014-01", "has_results": false, "last_update_posted_date": "2018-05-16", "last_synced_at": "2026-11-02T01:25:45.047Z", "location_count": 31, "location_summary": "Birmingham, Alabama • Escondido, California • Monterey, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Escondido", "state": "California" }, { "city": "Monterey", "state": "California" }, { "city": "Oxnard", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01252628" }, { "nct_id": "NCT02389907", "title": "Association Between Patients' Perceptions of Success in Post-op Pain Management and Overall Experience With Care", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Postoperative Pain" ], "interventions": [], "intervention_types": [], "sponsor": "The Medicines Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2015-06", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2018-04-26", "last_synced_at": "2026-11-02T01:25:45.047Z", "location_count": 9, "location_summary": "Bridgeport, Connecticut • Jupiter, Florida • Tamarac, Florida + 5 more", "locations": [ { "city": "Bridgeport", "state": "Connecticut" }, { "city": "Jupiter", "state": "Florida" }, { "city": "Tamarac", "state": "Florida" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Grand Rapids", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02389907" }, { "nct_id": "NCT00583492", "title": "Randomized Trial of Suicide Gene Therapy and Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Ad5-yCD/mutTKSR39rep-ADP", "type": "BIOLOGICAL" }, { "name": "IMRT", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "RADIATION" ], "sponsor": "Henry Ford Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 44, "start_date": "2007-12", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2016-03-17", "last_synced_at": "2026-11-02T01:25:45.047Z", "location_count": 2, "location_summary": "Baltimore, Maryland • Detroit, Michigan", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00583492" }, { "nct_id": "NCT01592136", "title": "Expanded Access Program of Ponatinib", "overall_status": "APPROVED_FOR_MARKETING", "study_type": "EXPANDED_ACCESS", "phases": [], "conditions": [ "Chronic Myeloid Leukemia (CML)", "Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)" ], "interventions": [ { "name": "ponatinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ariad Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2018-02-06", "last_synced_at": "2026-11-02T01:25:45.047Z", "location_count": 33, "location_summary": "La Jolla, California • San Marcos, California • Vallejo, California + 28 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "San Marcos", "state": "California" }, { "city": "Vallejo", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Altamonte Springs", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01592136" }, { "nct_id": "NCT00200109", "title": "Occipital Nerve Stimulation for the Treatment of Chronic Migraine Headache.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Chronic Migraine Headache" ], "interventions": [ { "name": "Occipital Nerve Stimulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "MedtronicNeuro", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 110, "start_date": "2004-05", "completion_date": "2011-05", "has_results": false, "last_update_posted_date": "2011-10-12", "last_synced_at": "2026-11-02T01:25:45.047Z", "location_count": 7, "location_summary": "Scottsdale, Arizona • Oceanside, California • Denver, Colorado + 4 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Oceanside", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00200109" }, { "nct_id": "NCT01497899", "title": "Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acquired Immunodeficiency Syndrome", "HIV Infections" ], "interventions": [ { "name": "E/C/F/TDF", "type": "DRUG" }, { "name": "E/C/F/TAF Placebo", "type": "DRUG" }, { "name": "E/C/F/TAF", "type": "DRUG" }, { "name": "E/C/F/TDF Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 279, "start_date": "2011-12-28", "completion_date": "2016-08-22", "has_results": true, "last_update_posted_date": "2018-11-19", "last_synced_at": "2026-11-02T01:25:45.047Z", "location_count": 40, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Beverly Hills, California + 30 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01497899" }, { "nct_id": "NCT02243072", "title": "Home-Based Interventions for Adolescents With Type 1 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 1 Diabetes" ], "interventions": [ { "name": "Fit Families plus Standard Medical Care", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Wayne State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "10 Years to 17 Years" }, "enrollment_count": 49, "start_date": "2014-12", "completion_date": "2016-07", "has_results": false, "last_update_posted_date": "2017-06-02", "last_synced_at": "2026-11-02T01:25:45.047Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02243072" } ] }